查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094215

動物腸道健康市場－2026-2032年全球市場預測

Animal Intestinal Health Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物腸道健康市場將成長至 68.8 億美元，複合年成長率為 6.17%。

主要市場統計數據
基準年 2025 45.2億美元
預計年份：2026年 47.9億美元
預測年份：2032年 68.8億美元
複合年成長率 (%) 6.17%

隨著生產者、獸醫、飼料生產商和監管機構將重點放在生產力、動物福利、食品安全和合理使用抗生素上，動物腸道健康已成為畜牧、家禽、水產養殖和伴侶動物領域的策略重點。健康的消化道有助於營養吸收、免疫功能、屏障功能、微生物群穩定性以及對沙門氏菌、大腸桿菌、產氣莢膜梭菌、球蟲和其他病原體的抵抗力。該行業正日益從被動治療轉向透過益生菌、益生元、後生元、有機酸、酵素、植物來源飼料添加劑、黴菌毒素應對措施、精準營養、疫苗接種策略、生物安全以及改進的畜牧管理來預防腸道健康。在全球範圍內，減少肉類和乳製品常規抗生素使用、提高永續蛋白質生產以及滿足消費者對安全、負責任養殖的肉類、牛奶、雞蛋和水產品的期望的壓力，正在推動對動物腸道健康解決方案的需求不斷成長。隨著生產系統日益集中化和供應鏈監控日益嚴格，腸道健康不再只是被視為一種飼料添加劑，而是一個將動物生產力、疾病預防、環境效率和公共衛生結果聯繫起來的綜合框架。

動物腸道健康領域的變革性變化

隨著監管、科學研究和生產等各領域優先事項的趨同，動物腸道健康領域正經歷一場變革。多個司法管轄區對抗生素生長促進劑使用的限制以及全球公共衛生機構發布的指南，正在加速推廣非抗生素腸道健康措施，特別是益生菌、益生元、有機酸、酶、酵母提取物、植物源性物質以及支持微生物組的營養方案。同時，生產者也意識到肉雞、蛋雞、豬、反芻動物、水產養殖動物和伴侶動物面臨的腸道健康挑戰各不相同，並正轉向針對不同物種和生命階段的策略。人們對抗生素抗藥性的日益關注正在重塑家禽和豬肉一體化生產系統的採購標準，而食品零售商和出口市場也越來越要求提供負責任的抗生素使用證明文件。總體基因體學、代謝體學、免疫學和黏膜生物學領域的科學進步正在加深我們對宿主-微生物組相互作用的理解，從而實現更有針對性的飼料配方。氣候壓力、飼料原料價格波動、黴菌毒素暴露以及疾病爆發等因素，進一步凸顯了健全的腸道健康管理方案的重要性。這些變化正促使各行業從單一產品替代轉向基於實證、可衡量且全面的腸道健康管理。

人工智慧對動物腸道健康的累積影響

人工智慧 (AI) 正透過改善疾病早期檢測、精準飼餵、微生物組分析和生產決策，穩步改變動物腸道健康。 AI 驅動的分析整合了飼料量、生長速度、飲水量、溫度、濕度、墊料品質、行為、糞便狀況、死亡模式和獸醫觀察等數據，以識別腸道菌群失衡、球蟲、壞死性小腸結腸炎、腹瀉、酸中毒和其他腸道疾病的早期預警訊號。在飼料配方方面，機器學習模型能夠根據物種、遺傳因素、生產階段、原料差異和健康狀況，實現更精確的營養平衡調整、酵素選擇、纖維最佳化和添加劑組合。 AI 也透過處理大規模基因組資料集，識別與提高飼料轉換率、增強免疫力和減少病原體排泄相關的微生物特徵，從而促進微生物組研究。利用電腦視覺、聲學監測和感測器的畜舍和農場平台為即時監測腸道健康創造了機遇，尤其是在家禽、豬、乳牛和水產養殖領域。這些協同效應正推動腸道健康管理模式從通用型轉變為預測性、適應性和結果導向型。然而，成功實施需要資料品質、農場層面的互通性、獸醫檢驗、網路安全以及透明的模型管治。

動物腸道健康的關鍵區域見解

亞太地區是動物腸道健康研究的中心區域，這得益於其大規模的家禽、生豬、​​水產養殖和乳牛生產基地，不斷成長的蛋白質消費量，以及在高密度養殖系統中持續改進飼料轉換率和疾病預防的努力。該地區各國在加強生物安全、減少抗生素依賴的同時，水產養殖戶也正在採用益生菌、有機酸、酵素和功能性飼料，以在集約化生產條件下維持動物腸道健康。北美地區擁有先進的獸醫基礎設施、強大的飼料創新能力、一體化的畜牧養殖模式，以及對家禽、乳牛、​​乳牛、肉牛和伴侶動物合理使用抗生素方案的強勁需求。該地區對可追溯性、動物福利和精準農業技術的重視，正在推動可衡量的腸道健康解決方案的應用。拉丁美洲以家禽、牛肉、豬肉和水產養殖的出口為主，其中巴西和墨西哥尤其注重提高生產力、飼料轉換率和病原體管理，以保持其在全球蛋白質貿易中的競爭力。歐洲擁有全球最成熟的動物抗生素使用法規環境之一，為預防性腸道健康計畫、營養干預和成熟的動物福利實踐提供了強勁動力。在中東，人們日益關注糧食安全、家禽生產、酪農發展和耐熱性，這使得腸道健康和營養效率的重要性日益凸顯。在非洲，為滿足不斷成長的人口糧食需求，畜禽養殖業的擴張帶來了更多機遇，因為腸道健康與疾病管理、飼料資源利用效率、小規模農戶生產力以及獸醫能力建設密切相關。

小組對動物腸道健康的關鍵見解

在東協，由於家禽、生豬、​​水產養殖和乳製品生產的擴張，以及對價格合理的動物蛋白需求的成長和熱帶生產環境中疾病預防措施的改進，動物腸道健康的重要性日益凸顯。該地區面臨熱應激、黴菌毒素風險和腸道疾病的威脅，因此促進了益生菌、酵素、有機酸、植物來源添加劑和飼料衛生改善等方面的應用。海灣合作理事會（GCC）成員國優先考慮糧食安全、可控的畜禽養殖系統、乳牛生產力和供應鏈韌性，並認知到腸道健康干預措施對於提高營養利用率和在炎熱乾燥條件下維持生產力的重要性。歐盟正在推動更廣泛地採用支持預防性營養、生物安全、疫苗接種和微生物組的解決方案，並為畜牧業合理使用抗生素制定全球標準。金磚國家共同構成了一個多元化且具影響力的動物性蛋白質生產系統。中國、印度、巴西、俄羅斯和南非在禽類、豬、反芻動物、水產養殖和小規模養殖方面各自面臨不同的腸道健康挑戰。七國集團（G7）國家在獸醫學、飼料技術、食品安全標準合規性和數位化畜牧管理方面普遍積極主動，致力於推動基於實證的腸道健康解決方案。北約成員國與北美和歐洲的先進動物健康和飼料市場高度重合，在這些市場中，供應鏈安全、生物安全和合理使用抗生素對於畜牧業和食品系統的韌性至關重要。

各國在動物腸道健康上的關鍵見解

美國在實施家禽、生豬、​​乳牛、牛、水產養殖和伴侶動物的綜合腸道健康策略方面處於全球領先地位，這得益於其對先進獸醫服務、飼料研究、精準牲畜監測以及合理使用抗生素記錄的強勁需求。加拿大高度重視動物福利、食品安全、合理使用抗生素和高品質飼料方案，尤其是在乳牛、家禽、乳牛和水產養殖領域。墨西哥在其不斷擴張的家禽、生豬和乳牛養殖業中，日益關注飼料轉換率、腸道疾病控制以及在氣候和生物安全條件波動的情況下提高生產力。巴西在全球家禽、肉牛、生豬和水產養殖供應鏈中扮演關鍵角色，腸道健康對於飼料轉換率、出口法規合規性、病原體減少和生產穩定性至關重要。英國持續推動減少抗生素使用、獸醫主導的畜群健康管理計畫以及以動物福利為中心的營養方案。在德國、法國、義大利和西班牙，由於法律規範嚴格、飼料產業成熟，且對常規抗生素替代療法的需求旺盛，腸道健康與永續畜牧業、乳牛生產力、家禽健康和生豬生產力密切相關。俄羅斯的畜禽業專注於自給自足、飼料轉換率和疾病預防，因此越來越重視支持腸道健康的營養管理和生物安全。中國大規模的生豬、家禽、水產養殖和酪農體系，畜牧業現代化進程不斷推進，並重視疾病風險管理，因此是動物腸道健康領域至關重要的國家。在印度，酪農、家禽養殖、水產養殖和小反芻動物養殖業需要一種可擴展的腸道健康管理方法，以提高生產力、增強動物免疫力並適應不同的農場結構。日本和韓國注重食品安全、動物營養、生物安全和技術驅動型生產，因此支持精準的腸道健康管理。在澳洲的畜牧業、酪農、家禽業和水產養殖業中，腸道健康與動物福利、環境效率、出口品質以及應對氣候變遷的能力息息相關。

業界領導者使用的實用建議

產業領導者應將動物腸道健康視為可衡量的績效和風險管理環節，而不僅僅是飼料添加劑選擇中的一個獨立決策。優先措施包括制定物種特異性的腸道健康方案、整合獸醫診斷和營養規劃，以及利用農場數據追蹤飼料轉換率、發病率、死亡率、糞便品質、病原體排泄、生長均勻性、產乳量、產蛋量和治療頻率等指標。飼料和動物健康相關人員應投資於經證實有效的益生菌、益生元、後生元、酵素、有機酸、植物萃取物、礦物質、纖維來源、黴菌毒素對抗措施和免疫支持營養素的組合，並根據生產階段和疾病風險進行調整。由於腸道健康受生產環境的顯著影響，生產者需要加強生物安全、水質管理、墊料管理、疫苗接種計劃、飼養密度管理和壓力緩解。實施人工智慧和精準農業工具的機構應優先考慮資料互通性、清晰的獸醫監管以及在田間層面提供可操作的決策支援。為了贏得客戶和監管機構的信任，管理者應記錄其在合理使用抗生素、改善動物福利和食品安全方面的成就。獸醫、營養學家、生產商、學術界和監管機構之間的合作對於將腸道微生物組的科學成果轉化為可重複的商業性效益至關重要。

調查方法

本執行摘要採用結構化的二手研究方法編寫，重點關注來自獸醫學、動物營養學、公共衛生、食品安全、農業和監管領域的檢驗且公開的資訊。該調查方法強調研究途徑來自同行評審研究、國際動物衛生指南、抗菌素抗藥性框架、食品生產標準、政府農業出版刊物、獸醫協會資料以及關於腸道菌群、腸道疾病、飼料添加劑和精準動物養殖的科學文獻的證據進行檢驗。研究結果涵蓋多種動物類型，包括家禽、豬、反芻動物、水產養殖和伴侶動物，以及不同地區、國家群體和主要國家生產系統。本分析不涉及市場規模、市場佔有率和收入估算及預測；而是著重於可觀察的行業促進因素、監管趨勢、技術應用、生產挑戰以及基於證據的應用案例。關鍵主題透過多個可靠資訊來源的一致性檢驗，這些來源包括抗生素合理使用、微生物組研究、飼料創新、動物福利標準、生物安全措施和數位監測等方面的記錄變化。這種方法在保持準確性、相關性和對決策者實際適用性的同時，客觀地呈現了動物腸道健康的觀點。

結論

動物腸道健康如今已成為永續畜牧業、食品安全、合理使用抗生素和動物福利的基石。這一領域正從廣泛的營養支持發展成為一個綜合性的科學系統，該系統結合了微生物組管理、精準飼餵、預防性獸醫護理、農場生物安全、環境控制和數位監測。儘管亞太、北美、拉丁美洲、歐洲以及中東和非洲的生產者面臨不同的生產挑戰，但他們都通用需要改善腸道健康、提高營養利用率、增強抗病能力並合理使用抗生素。人工智慧、微生物組科學和先進的飼料技術正在提升產業早期發現腸道健康問題並更有效地制定乾預措施的能力。能夠檢驗結果、實施物種特異性解決方案並將腸道健康計劃與生產力、福祉、永續性和公共衛生方面的可衡量改進聯繫起來的相關人員。隨著全球對安全且負責任生產的動物性蛋白質的需求持續成長，腸道健康預計將繼續成為一項至關重要的競爭和營運重點。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：動物腸道健康市場：依產品類型分類

  • 酵素
    • 植酸酶
    • 蛋白酶
    • 木聚醣酶
  • 有機酸
  • 植物源
  • 益生元
  • 益生菌
    • 細菌益生菌
    • 酵母益生菌
  • 酵母及酵母衍生產品

第8章：動物腸道健康市場：依動物類型分類

  • 水產養殖
    • 魚
    • 蝦
  • 伴侶動物
    • 貓
    • 狗
  • 家禽
    • 肉雞
    • 產蛋母雞
    • 火雞
  • 反芻動物
    • 肉牛
    • 乳牛
    • 綿羊和山羊
  • 豬
    • 種豬
    • 仔豬和肥育豬
    • 母豬和小豬

第9章：動物腸道保健市場：以劑型分類

  • 液體
  • 顆粒
  • 粉末

第10章：動物腸道保健市場：依給藥途徑分類

  • 飼料添加
  • 飲用水管理
  • 直介面服給藥
    • 注射器
    • 膠囊和片劑
    • 咀嚼片
    • 腸外
  • 注射藥物
  • 環境或孵化場
  • 噴霧劑

第11章 動物腸道健康市場：依應用領域分類

  • 飼料添加劑
  • 營養補充品
  • 治療用途

第12章：動物腸道健康市場：依分銷管道分類

  • 離線
    • 直銷
    • 銷售代理
  • 線上

第13章：動物腸道健康市場：依客戶類型分類

  • 綜合畜牧養殖業務
  • 獨立農場和牧場
  • 飼料業的客戶
  • 營養相關企業
  • 獸醫醫院和診所

第14章：動物腸道健康市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：動物腸道健康市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：動物腸道健康市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Alltech, Inc.
  • Anpario plc
  • Archer-Daniels-Midland Company
  • Balchem Corporation
  • BASF SE
  • BioZyme Incorporated
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Church & Dwight Co., Inc.
  • Dr. Eckel Animal Nutrition GmbH & Co. KG
  • DSM-Firmenich AG
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • EW Nutrition GmbH
  • International Flavors & Fragrances Inc.
  • Kemin Industries, Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • Lesaffre International, SAS
  • Norel, SA
  • Nor-Feed SAS
  • Novozymes A/S
  • Olmix SA
  • Orffa International Holding BV
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Vland BIoTech Inc.
  • Zoetis Inc.
Product Code: MRR-501246438090

The Animal Intestinal Health Market is projected to grow by USD 6.88 billion at a CAGR of 6.17% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.52 billion
Estimated Year [2026] USD 4.79 billion
Forecast Year [2032] USD 6.88 billion
CAGR (%) 6.17%

Animal intestinal health has become a strategic priority across livestock, poultry, aquaculture, and companion animal systems as producers, veterinarians, feed formulators, and regulators focus on productivity, welfare, food safety, and antimicrobial stewardship. A healthy gastrointestinal tract supports nutrient absorption, immune competence, barrier integrity, microbiome stability, and resilience against enteric pathogens such as Salmonella, Escherichia coli, Clostridium perfringens, coccidia, and other disease-causing organisms. The industry is increasingly shifting from reactive treatment toward preventive gut health management through probiotics, prebiotics, postbiotics, organic acids, enzymes, phytogenic feed additives, mycotoxin mitigation, precision nutrition, vaccination strategies, biosecurity, and improved husbandry. Demand for animal intestinal health solutions is reinforced by global pressure to reduce routine antibiotic use in food-producing animals, strengthen sustainable protein production, and meet consumer expectations for safe, responsibly raised meat, milk, eggs, and seafood. As production systems become more intensive and supply chains more scrutinized, intestinal health is no longer viewed as a narrow feed additive category but as an integrated framework connecting animal performance, disease prevention, environmental efficiency, and public health outcomes.

Transformative Shifts in the Animal Intestinal Health Landscape

The animal intestinal health landscape is undergoing transformative change as regulatory, scientific, and production priorities converge. Restrictions on antibiotic growth promoters in multiple jurisdictions and global guidance from public health authorities have accelerated adoption of non-antibiotic gut health interventions, especially probiotics, prebiotics, organic acids, enzymes, yeast derivatives, phytogenics, and microbiome-supporting nutrition programs. At the same time, producers are moving toward species-specific and life-stage-specific strategies, recognizing that intestinal health challenges differ between broilers, layers, swine, ruminants, aquaculture species, and companion animals. The rise of antimicrobial resistance awareness has reshaped procurement standards across integrated poultry and pork systems, while food retailers and export markets increasingly require documentation of responsible antibiotic use. Scientific advances in metagenomics, metabolomics, immunology, and mucosal biology are improving understanding of host-microbiome interactions and enabling more targeted feed formulations. Climate stress, feed ingredient volatility, mycotoxin exposure, and disease outbreaks are further increasing the need for resilient gut health programs. These shifts are pushing the sector toward evidence-based, measurable, and integrated intestinal health management rather than single-product substitution.

Cumulative Impact of Artificial Intelligence on Animal Intestinal Health

Artificial intelligence is steadily reshaping animal intestinal health by improving early disease detection, precision feeding, microbiome analysis, and production decision-making. AI-enabled analytics can integrate feed intake, growth rate, water consumption, temperature, humidity, litter quality, behavior, fecal consistency, mortality patterns, and veterinary observations to identify early warning signals of gut dysbiosis, coccidiosis, necrotic enteritis, diarrhea, acidosis, or other intestinal disorders. In feed formulation, machine learning models can support more precise nutrient balancing, enzyme selection, fiber optimization, and additive combinations based on species, genetics, production stage, raw material variability, and health status. AI also enhances microbiome research by processing large genomic datasets to identify microbial signatures associated with improved feed conversion, immune resilience, and reduced pathogen shedding. Computer vision, acoustic monitoring, and sensor-based barn or farm platforms are creating opportunities for real-time intestinal health surveillance, particularly in poultry, swine, dairy, and aquaculture. The cumulative impact is a transition from generalized gut health programs to predictive, adaptive, and outcome-based management. However, successful adoption depends on data quality, farm-level interoperability, veterinary validation, cybersecurity, and transparent model governance.

Key Regional Insights for Animal Intestinal Health

Asia-Pacific is a central region for animal intestinal health because of its large poultry, swine, aquaculture, and dairy production base, rising protein consumption, and ongoing efforts to improve feed efficiency and disease prevention in high-density farming systems. Countries across the region are strengthening biosecurity and reducing reliance on antibiotics, while aquaculture producers are adopting probiotics, organic acids, enzymes, and functional feeds to manage gut integrity under intensive production conditions. North America is characterized by advanced veterinary infrastructure, strong feed innovation, integrated livestock operations, and robust demand for antibiotic stewardship programs in poultry, swine, dairy, beef, and companion animal care. The region's focus on traceability, animal welfare, and precision livestock technologies supports adoption of measurable intestinal health solutions. Latin America is shaped by major poultry, beef, pork, and aquaculture export activity, with Brazil and Mexico emphasizing productivity, feed conversion, and pathogen control to maintain competitiveness in global protein trade. Europe has one of the most mature regulatory environments for reduced antibiotic use in animals, creating strong momentum for preventive gut health programs, nutritional interventions, and documented animal welfare practices. The Middle East is increasingly focused on food security, poultry production, dairy development, and heat-stress resilience, which elevates the importance of intestinal integrity and nutrient efficiency. Africa presents growing opportunities as livestock and poultry production expand to meet population-driven food demand, with intestinal health linked to disease control, feed resource efficiency, smallholder productivity, and veterinary capacity building.

Key Group Insights for Animal Intestinal Health

ASEAN countries are becoming increasingly important in animal intestinal health due to expanding poultry, swine, aquaculture, and dairy production, combined with rising demand for affordable animal protein and improved disease prevention in tropical production environments. The region's exposure to heat stress, mycotoxin risk, and enteric disease pressure supports adoption of probiotics, enzymes, organic acids, phytogenic additives, and improved feed hygiene. The GCC is prioritizing food security, controlled-environment livestock and poultry systems, dairy productivity, and supply chain resilience, making gut health interventions relevant for improving nutrient utilization and maintaining performance under hot and arid conditions. The European Union has been a global reference point for antimicrobial stewardship in animal agriculture, encouraging wider use of preventive nutrition, biosecurity, vaccination, and microbiome-supporting solutions. BRICS economies collectively represent diverse and influential animal protein systems, with China, India, Brazil, Russia, and South Africa each facing distinct gut health priorities across poultry, swine, ruminants, aquaculture, and smallholder farming. G7 countries generally show strong adoption of veterinary science, feed technology, food safety compliance, and digital livestock management, supporting evidence-based intestinal health solutions. NATO member countries overlap significantly with advanced animal health and feed markets in North America and Europe, where supply chain security, biosecurity, and responsible antimicrobial use are central to livestock and food system resilience.

Key Country Insights for Animal Intestinal Health

The United States is a leading adopter of integrated intestinal health strategies across poultry, swine, dairy, beef, aquaculture, and companion animals, supported by advanced veterinary services, feed research, precision livestock monitoring, and strong pressure to document responsible antibiotic use. Canada emphasizes animal welfare, food safety, antimicrobial stewardship, and high-quality feed programs, particularly in dairy, poultry, pork, and aquaculture. Mexico's expanding poultry, pork, and dairy sectors are increasingly focused on feed efficiency, enteric disease control, and productivity under variable climatic and biosecurity conditions. Brazil plays a major role in global poultry, beef, pork, and aquaculture supply chains, making gut health essential for feed conversion, export compliance, pathogen reduction, and production consistency. The United Kingdom continues to advance antibiotic reduction, veterinary-led herd and flock health planning, and welfare-driven nutrition programs. Germany, France, Italy, and Spain are shaped by strong regulatory oversight, established feed industries, and demand for alternatives to routine antibiotic use, with intestinal health linked to sustainable livestock production, dairy performance, poultry health, and swine productivity. Russia's livestock and poultry sectors are focused on self-sufficiency, feed efficiency, and disease prevention, increasing attention to gut-supportive nutrition and biosecurity. China is a critical country for animal intestinal health because of its extensive swine, poultry, aquaculture, and dairy systems, ongoing modernization of animal production, and emphasis on disease risk management. India's dairy, poultry, aquaculture, and small ruminant sectors require scalable gut health approaches that improve productivity, support animal immunity, and fit diverse farm structures. Japan and South Korea emphasize high standards for food safety, animal nutrition, biosecurity, and technology-enabled production, supporting precise intestinal health management. Australia's livestock, dairy, poultry, and aquaculture systems link gut health with animal welfare, environmental efficiency, export quality, and resilience under climate variability.

Actionable Recommendations for Industry Leaders

Industry leaders should treat animal intestinal health as a measurable performance and risk-management discipline rather than a standalone feed additive decision. Priority actions include building species-specific gut health protocols, integrating veterinary diagnostics with nutrition planning, and using farm data to track outcomes such as feed conversion, morbidity, mortality, fecal quality, pathogen shedding, growth uniformity, milk yield, egg production, and treatment frequency. Feed and animal health stakeholders should invest in validated combinations of probiotics, prebiotics, postbiotics, enzymes, organic acids, phytogenics, minerals, fiber sources, mycotoxin control, and immune-supporting nutrients based on production stage and disease pressure. Producers should strengthen biosecurity, water quality management, litter or bedding control, vaccination programs, stocking density management, and stress reduction because intestinal health is strongly influenced by the production environment. Organizations adopting AI and precision livestock tools should prioritize interoperable data systems, clear veterinary oversight, and practical farm-level decision support. To build trust with customers and regulators, leaders should document antimicrobial stewardship, animal welfare improvements, and food safety outcomes. Collaboration between veterinarians, nutritionists, producers, academic experts, and regulators will be essential to translate gut microbiome science into repeatable commercial results.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified and publicly available information from veterinary science, animal nutrition, public health, food safety, agriculture, and regulatory sources. The methodology emphasizes triangulation of evidence from peer-reviewed research, international animal health guidance, antimicrobial resistance frameworks, food production standards, government agriculture publications, veterinary association materials, and scientific literature on gut microbiota, enteric disease, feed additives, and precision livestock farming. Insights are assessed across species, including poultry, swine, ruminants, aquaculture, and companion animals, and across regions, country groups, and key national production systems. The analysis avoids market sizing, market share, revenue estimates, and forecasts, focusing instead on observable industry drivers, regulatory trends, technology adoption, production challenges, and evidence-backed applications. Key themes are validated through consistency across multiple credible sources, including documented shifts in antibiotic stewardship, microbiome research, feed innovation, animal welfare standards, biosecurity practices, and digital monitoring. This approach supports an objective, view of animal intestinal health while maintaining accuracy, relevance, and practical utility for decision-makers.

Conclusion

Animal intestinal health is now a foundational pillar of sustainable animal production, food safety, antimicrobial stewardship, and animal welfare. The sector is advancing from broad nutritional support toward integrated, science-based systems that combine microbiome management, precision feeding, preventive veterinary care, farm biosecurity, environmental control, and digital monitoring. Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa, producers face different production pressures but share a common need to improve gut integrity, nutrient efficiency, disease resilience, and responsible antibiotic practices. AI, microbiome science, and advanced feed technologies are expanding the industry's ability to detect intestinal health challenges earlier and tailor interventions more precisely. The most successful stakeholders will be those that validate outcomes, align solutions with species-specific needs, and connect gut health programs to measurable improvements in productivity, welfare, sustainability, and public health. As global demand for safe and responsibly produced animal protein continues to rise, intestinal health will remain a critical competitive and operational priority.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Intestinal Health Market, by Product Type

  • 7.1. Introduction
  • 7.2. Enzymes
    • 7.2.1. Phytase
    • 7.2.2. Protease
    • 7.2.3. Xylanase
  • 7.3. Organic Acids
  • 7.4. Phytogenics
  • 7.5. Prebiotics
  • 7.6. Probiotics
    • 7.6.1. Bacterial Probiotics
    • 7.6.2. Yeast Probiotics
  • 7.7. Yeast & Yeast Derivatives

8. Animal Intestinal Health Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Aquaculture
    • 8.2.1. Fish
    • 8.2.2. Shrimp
  • 8.3. Companion Animals
    • 8.3.1. Cat
    • 8.3.2. Dog
  • 8.4. Poultry
    • 8.4.1. Broiler
    • 8.4.2. Layer
    • 8.4.3. Turkey
  • 8.5. Ruminants
    • 8.5.1. Beef Cattle
    • 8.5.2. Dairy Cattle
    • 8.5.3. Sheep And Goat
  • 8.6. Swine
    • 8.6.1. Breeder
    • 8.6.2. Grower Finisher
    • 8.6.3. Sow And Piglet

9. Animal Intestinal Health Market, by Formulation

  • 9.1. Introduction
  • 9.2. Liquid
  • 9.3. Pellet
  • 9.4. Powder

10. Animal Intestinal Health Market, by Route Of Administration

  • 10.1. Introduction
  • 10.2. In-Feed
  • 10.3. In-Water
  • 10.4. Oral Direct-Dose
    • 10.4.1. Syringes
    • 10.4.2. Capsules & Tablets
    • 10.4.3. Chews
    • 10.4.4. Parenteral
  • 10.5. Injectable Therapies
  • 10.6. Environmental Or Hatchery
  • 10.7. Spray Applications

11. Animal Intestinal Health Market, by Application

  • 11.1. Introduction
  • 11.2. Feed Additive
  • 11.3. Nutritional Supplement
  • 11.4. Therapeutic

12. Animal Intestinal Health Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
    • 12.2.1. Direct Sales
    • 12.2.2. Distributor
  • 12.3. Online

13. Animal Intestinal Health Market, by Customer Type

  • 13.1. Introduction
  • 13.2. Integrated Livestock Producers
  • 13.3. Independent Farms & Ranches
  • 13.4. Feed Industry Customers
  • 13.5. Nutrition Companies
  • 13.6. Veterinary Clinics & Hospitals

14. Animal Intestinal Health Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Animal Intestinal Health Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Intestinal Health Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Alltech, Inc.
  • 18.2. Anpario plc
  • 18.3. Archer-Daniels-Midland Company
  • 18.4. Balchem Corporation
  • 18.5. BASF SE
  • 18.6. BioZyme Incorporated
  • 18.7. Boehringer Ingelheim International GmbH
  • 18.8. Cargill, Incorporated
  • 18.9. Ceva Sante Animale
  • 18.10. Church & Dwight Co., Inc.
  • 18.11. Dr. Eckel Animal Nutrition GmbH & Co. KG
  • 18.12. DSM-Firmenich AG
  • 18.13. Elanco Animal Health Incorporated
  • 18.14. Evonik Industries AG
  • 18.15. EW Nutrition GmbH
  • 18.16. International Flavors & Fragrances Inc.
  • 18.17. Kemin Industries, Inc.
  • 18.18. Kerry Group plc
  • 18.19. Lallemand Inc.
  • 18.20. Lesaffre International, SAS
  • 18.21. Norel, S.A.
  • 18.22. Nor-Feed S.A.S.
  • 18.23. Novozymes A/S
  • 18.24. Olmix SA
  • 18.25. Orffa International Holding B.V.
  • 18.26. Phibro Animal Health Corporation
  • 18.27. Vetoquinol SA
  • 18.28. Virbac S.A.
  • 18.29. Vland Biotech Inc.
  • 18.30. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHYTASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHYTASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHYTASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROTEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROTEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROTEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL XYLANASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL XYLANASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL XYLANASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORGANIC ACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORGANIC ACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORGANIC ACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHYTOGENICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHYTOGENICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHYTOGENICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PREBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PREBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PREBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIAL PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIAL PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL YEAST PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL YEAST PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL YEAST PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL YEAST & YEAST DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL YEAST & YEAST DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL YEAST & YEAST DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHRIMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHRIMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SHRIMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DOG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DOG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BROILER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BROILER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BROILER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LAYER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LAYER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LAYER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TURKEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TURKEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TURKEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RUMINANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RUMINANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RUMINANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHEEP AND GOAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SHEEP AND GOAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHEEP AND GOAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREEDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BREEDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREEDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GROWER FINISHER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GROWER FINISHER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GROWER FINISHER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SOW AND PIGLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SOW AND PIGLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SOW AND PIGLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PELLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PELLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PELLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POWDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POWDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IN-FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IN-WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IN-WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ORAL DIRECT-DOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ORAL DIRECT-DOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORAL DIRECT-DOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPSULES & TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPSULES & TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPSULES & TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CHEWS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CHEWS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CHEWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENVIRONMENTAL OR HATCHERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ENVIRONMENTAL OR HATCHERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENVIRONMENTAL OR HATCHERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SPRAY APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SPRAY APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SPRAY APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FEED ADDITIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FEED ADDITIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FEED ADDITIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NUTRITIONAL SUPPLEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NUTRITIONAL SUPPLEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NUTRITIONAL SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTEGRATED LIVESTOCK PRODUCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL INTEGRATED LIVESTOCK PRODUCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTEGRATED LIVESTOCK PRODUCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL INDEPENDENT FARMS & RANCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL INDEPENDENT FARMS & RANCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL INDEPENDENT FARMS & RANCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL FEED INDUSTRY CUSTOMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL FEED INDUSTRY CUSTOMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL FEED INDUSTRY CUSTOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NUTRITION COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NUTRITION COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NUTRITION COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 296. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 300. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 301. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 302. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 303. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 304. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 305. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 306. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 309. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 345. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 347. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 348. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 350. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 351. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 352. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 353. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 354. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 355. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 356. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORAL DIRECT-DOSE, 2018-2032 (USD MILLION)
  • TABLE 357. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 358. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 359. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 360. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CUSTOMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 361. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 362. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 364. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 365. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 366. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 367. NATO